Anal Dilatation Plus Probiotics Before Ileostomy Reduction for Low Anterior Resection Syndrome
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This is randomized, phase 2 trial in patients with rectal cancer undergoing
sphincter-preserving proctectomy and temporary ileostomy, to explore the effects of anal
dilatation plus probiotics administered per anus before ileostomy reduction in relieving
postoperative bowel dysfunction known as low anterior resection syndrome (LARS).